Account
Insider Insights
04.07.2024
Hemgenix becomes the first treatment to enter NHS ...

New ground-breaking gene therapy for haemophilia B enters NHS England's Innovative Medicines Fund, o...

Read more
News
29.06.2022
PMA Insights: Week 26

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
09.06.2022
What is the New Innovative Medicines Fund and What...

The Innovative Medicines Fund launched on 7th June 2022 The Innovative Medicines Fund (IMF), which w...

Read more
News
24.11.2021
PMA Insights: Week 47 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch